AbbVie, Inc. (ABBV)
228.59
+3.78
(+1.68%)
USD |
NYSE |
Feb 23, 13:33
AbbVie Research and Development Expense (Quarterly) : 2.579B for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amgen, Inc. | 2.151B |
| Biogen, Inc. | 434.00M |
| Gilead Sciences, Inc. | 1.565B |
| Johnson & Johnson | 4.268B |
| Eli Lilly & Co. | 3.802B |